Markets

Teva Pharmaceutical Industries Limited Q3 adjusted earnings Miss Estimates

(RTTNews) - Below are the earnings highlights for Teva Pharmaceutical Industries Limited (TEVA):

-Earnings: -$314 million in Q3 vs. -$273 million in the same period last year. -EPS: -$0.29 in Q3 vs. -$0.27 in the same period last year. -Excluding items, Teva Pharmaceutical Industries Limited reported adjusted earnings of $637 million or $0.58 per share for the period. -Analysts projected $0.59 per share -Revenue: $4.26 billion in Q3 vs. $4.53 billion in the same period last year.

-Guidance: Full year EPS guidance: $2.30 - $2.50 Full year revenue guidance: $17.2 - $ 17.4 Bln

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In This Story

TEVA

Latest Markets Videos

    RTTNews

    Founded in the late 1990s by Andrew Mariathasan in New York, with the goal of covering Wall Street for a new generation of investors, RTTNews has expanded steadily over the years to become a trusted provider of content for a wide array of subjects across several platforms. RTT's Financial Newswire is relied upon by some of the world's largest financial institutions, including banks, brokerages, trading platforms and financial exchanges.

    Learn More